Metraipolis › archive › dc_fdaf45c322fb

Treatment of Relapsed/Refractory t(11;14) Multiple Myeloma and High-Risk Myelodysplastic Syndrome With Venetoclax — Europe PMC PMID:41439211

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41439211
DOI
10.1155/crh/6491283
License (as archived)
solo-consultazione
Archived
2026-11-07T17:08:55.113Z
SHA-256 of the archived text
096ee9013d18c46e6901a9da3857798775424fb053de43fceaf55cf23a2c5292
Stable URL of this page
https://metraipolis.com/documento/dc_fdaf45c322fb

How to cite

Treatment of Relapsed/Refractory t(11;14) Multiple Myeloma and High-Risk Myelodysplastic Syndrome With Venetoclax — Europe PMC PMID:41439211 — Europe PMC (en), https://europepmc.org/article/MED/41439211 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fdaf45c322fb (Metraipolis archive dc_fdaf45c322fb, sha256 096ee9013d18c46e6901a9da3857798775424fb053de43fceaf55cf23a2c5292)
BibTeX
@misc{dcfdaf45c322fb,
  title = {Treatment of Relapsed/Refractory t(11;14) Multiple Myeloma and High-Risk Myelodysplastic Syndrome With Venetoclax — Europe PMC PMID:41439211},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41439211},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fdaf45c322fb; sha256 096ee9013d18c46e6901a9da3857798775424fb053de43fceaf55cf23a2c5292},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41439211. Agents can read the archived copy with the MCP tool read_document.